Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials
- 12 December 2001
- Vol. 93 (6) , 409-414
- https://doi.org/10.1002/cncr.10138
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Short-Term Kinetics of Tumor Antigen Expression in Response to VaccinationThe Journal of Immunology, 2001
- Immune selection after antigen-specific immunotherapy of melanomaSurgery, 1999
- Melanoma-associated antigen recognized by T cells (MART-1)Cancer, 1999
- Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivoInternational Journal of Cancer, 1998
- Differences in Frequency Distribution of HLA-A2 Subtypes Between North American and Italian White Melanoma Patients: Relevance for Epitope Specific Vaccination ProtocolsJournal of Immunotherapy, 1996
- Analysis of Expression of the Melanoma-Associated Antigens MART-1 and gp lOO in Metastatic Melanoma Cell Lines and in In Situ LesionsJournal of Immunotherapy, 1996
- Vitiligo in Patients with MelanomaJournal of Immunotherapy, 1996
- HLA Associations in the Antitumor Response Against Malignant MelanomaJournal of Immunotherapy, 1995
- Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.Proceedings of the National Academy of Sciences, 1994
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.Proceedings of the National Academy of Sciences, 1994